Economical approaches to meeting global demand for high value biopharmaceuticals
While biopharmaceutical products are the growth engine of today’s global pharmaceutical market, their high cost and foreign manufacture make them expensive and difficult to obtain in many emerging markets such as Brazil, China, and Russia. These countries want to provide top tier medical care to their citizens but struggle to pay for these expensive therapies for all patients who need them. As innovator biopharmaceutical products come off patent, the emergence of lower cost biosimilars promises to significantly improve worldwide patient access to these life-saving therapies and presents the greatest opportunity for expanding the pharmaceutical market worldwide. By using local manufacturing facilities, modern, state‑of‑the‑art manufacturing technologies, and efficient manufacturing approaches including single-use technologies, the international biopharmaceutical industry can meet these challenges and improve healthcare options worldwide. Once such option, incorporating a modular facility design and maximum use of single-use technologies will be presented.